<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2011-2-104-109</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-1369</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОТ НАУКИ К ПРАКТИКЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>FROM SCIENCE TO PRACTICE</subject></subj-group></article-categories><title-group><article-title>Ассоциация полиморфизма гена аполипопротеина Е и липидного спектра с различными типами инсульта в Сибири</article-title><trans-title-group xml:lang="en"><trans-title>Assoclation polymorphism apoe gene and blood lipid profile with diffe different types of stroke in Siberia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воевода</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Voevoda</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, профессор, член-корреспондент РАМН, директор</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скурихина</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Skurikhina</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Скурихина Юлия Владимировна, соискатель, врач-невролог </p><p>тел. 8-913-748-6567</p></bio><email xlink:type="simple">julia.sku@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шишкин</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shishkin</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, ст. науч. сотрудник лаборатории клинико-популяционных и профилактических исследований терапевтических и эндокринных заболеваний</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>НИИ терапии СО РАМН</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>28</day><month>04</month><year>2011</year></pub-date><volume>10</volume><issue>2</issue><fpage>104</fpage><lpage>109</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Воевода М.И., Скурихина Ю.В., Шишкин С.В., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">Воевода М.И., Скурихина Ю.В., Шишкин С.В.</copyright-holder><copyright-holder xml:lang="en">Voevoda M.I., Skurikhina Y.V., Shishkin S.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/1369">https://bulletin.ssmu.ru/jour/article/view/1369</self-uri><abstract><p>Представлено исследование ассоциации полиморфизма гена APOE с определенными типами инсульта, а также ассоциации показателей липидного профиля и различных типов инсульта в зависимости от пола в условиях крупного города Западной Сибири (г. Новосибирск).</p><p>Cлучаи мозгового инсульта регистрировались в репрезентативной целевой популяции с общей численностью жителей около 150 тыс. человек в соответствии с критериями программы Всемирной организации здравоохранения MONICA и предшествующей программы «Регистр мозгового инсульта». В 2003—2007 гг. среди выявленных новых и повторных случаев инсульта была сформирована случайная 15%-я выборка (261 человека). Средний возраст развития инсульта у мужчин составил (61,3 ± 1,0) года, у женщин — (66,1 ± 0,9) года.</p><p>У больных различными типами инсульта не выявлено независимого влияния полиморфизма генотипов гена APOE на развитие определенных типов инсульта.</p></abstract><trans-abstract xml:lang="en"><p>The present research aimed at studying association between Apo E polymorphism and certain types of stroke and also association factors of lipid profile’s results and different types of stroke it depends on sex and conditions of living in typical West Siberian megapolis (Novosibirsk).</p><p>The causes of brain stroke were registered in representative population with population about 150 000 in according to standarts of WHO program MONICA and previous program «Register of stroke». From 2003 to 2007 among new registered and repeated causes of stroke was form at random 15% sample (261 patients). The average age of stroke attack is 61,3 ± 1,0 for men and 61,3 ± 1,0 for women.</p><p>Independent influence of APOE gene's genotypes polymorphism on development at different stroke patients has not been revealed.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инсульт</kwd><kwd>ген APOE</kwd><kwd>полиморфизм</kwd><kwd>липидный состав крови</kwd><kwd>пол</kwd><kwd>возраст</kwd></kwd-group><kwd-group xml:lang="en"><kwd>stroke</kwd><kwd>gene APOE</kwd><kwd>polymorphism</kwd><kwd>plasma lipids</kwd><kwd>gender</kwd><kwd>age</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Боринская С.А., Кальина Н.Р., Санина Е.Д. и др. Полиморфизм гена аполипопротеина Е в популяциях России и сопредельных стран//Генетика. 2007. Т. 43, № 10. С. 1434-1439.</mixed-citation><mixed-citation xml:lang="en">Боринская С.А., Кальина Н.Р., Санина Е.Д. и др. Полиморфизм гена аполипопротеина Е в популяциях России и сопредельных стран//Генетика. 2007. Т. 43, № 10. С. 1434-1439.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Гланц С. Медико-биологическая статистика/пер. Ю.А. Данилова; под ред. Н.Е. Бузикашвили, Д.В. Самойлова. М.: Практика, 1999. 459 с.</mixed-citation><mixed-citation xml:lang="en">Гланц С. Медико-биологическая статистика/пер. Ю.А. Данилова; под ред. Н.Е. Бузикашвили, Д.В. Самойлова. М.: Практика, 1999. 459 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ Statistica. М.: МедиаСфера, 2002. 312 с.</mixed-citation><mixed-citation xml:lang="en">Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ Statistica. М.: МедиаСфера, 2002. 312 с.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Смит К., Клико С., Кантор Ч. Пульс-электрофорез и методы работы с большими молекулами ДНК//Анализ генома. Методы: пер. с англ. М.: Мир, 1990. С. 58-94.</mixed-citation><mixed-citation xml:lang="en">Смит К., Клико С., Кантор Ч. Пульс-электрофорез и методы работы с большими молекулами ДНК//Анализ генома. Методы: пер. с англ. М.: Мир, 1990. С. 58-94.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Aho К., Harmsen P., Hatano S. et al. Cerebrovascular diseases in the community: Results of the WHO collaborative Study//Bull. WHO. 1980. № 58 (1). Р. 113-130.</mixed-citation><mixed-citation xml:lang="en">Aho К., Harmsen P., Hatano S. et al. Cerebrovascular diseases in the community: Results of the WHO collaborative Study//Bull. WHO. 1980. № 58 (1). Р. 113-130.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Asplund K., Bonita R., Kuulasmaa K. et al. Multinational comparisons of stroke epidemiology: evaluation of case ascertainment in the WHO MONICA stroke study//Stroke. 1995.26 (3). Р. 355-360.</mixed-citation><mixed-citation xml:lang="en">Asplund K., Bonita R., Kuulasmaa K. et al. Multinational comparisons of stroke epidemiology: evaluation of case ascertainment in the WHO MONICA stroke study//Stroke. 1995.26 (3). Р. 355-360.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bhatia M., Howard S.C., Clark T.G. et al. Apolipoproteins as predictors of ischaemic stroke in patients with a previous transient ischaemic attack//Cerebrovasc. Dis. 2006. № 21. Р. 323-328.</mixed-citation><mixed-citation xml:lang="en">Bhatia M., Howard S.C., Clark T.G. et al. Apolipoproteins as predictors of ischaemic stroke in patients with a previous transient ischaemic attack//Cerebrovasc. Dis. 2006. № 21. Р. 323-328.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Castelli W.P., Anderson K., Wilson P.W. et al. Lipids and risk of coronary heart disease: the Framingham Study//Ann. Epidemiol. 1992. № 2. Р. 23-28.</mixed-citation><mixed-citation xml:lang="en">Castelli W.P., Anderson K., Wilson P.W. et al. Lipids and risk of coronary heart disease: the Framingham Study//Ann. Epidemiol. 1992. № 2. Р. 23-28.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Corbo R.M, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE ε4 a thrifty allele?//Ann. Hum. Genet. 1999. 63 (4). Р. 301-310.</mixed-citation><mixed-citation xml:lang="en">Corbo R.M, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE ε4 a thrifty allele?//Ann. Hum. Genet. 1999. 63 (4). Р. 301-310.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Couderc R., Mahieux F., Bailleul S. et al. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study//Stroke. 1993. 24. Р. 661-664.</mixed-citation><mixed-citation xml:lang="en">Couderc R., Mahieux F., Bailleul S. et al. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study//Stroke. 1993. 24. Р. 661-664.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Das H.K., McPherson G.A., Bruns, S.K. et al. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene//J. Biol. Chem. 1985. 260. Р. 6240-6247.</mixed-citation><mixed-citation xml:lang="en">Das H.K., McPherson G.A., Bruns, S.K. et al. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene//J. Biol. Chem. 1985. 260. Р. 6240-6247.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI//J. Lipid. Res. 1990. 31 (3). Р. 545-8.</mixed-citation><mixed-citation xml:lang="en">Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI//J. Lipid. Res. 1990. 31 (3). Р. 545-8.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kent D.M. Stroke -An Equal Opportunity for the Initiation of Statin Therapy//N. Engl. J. Med. 2006. 355 (6). Р. 613-615.</mixed-citation><mixed-citation xml:lang="en">Kent D.M. Stroke -An Equal Opportunity for the Initiation of Statin Therapy//N. Engl. J. Med. 2006. 355 (6). Р. 613-615.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lambert J.-C., Brousseau T., Defoss et al. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations. the ECTIM Study // Hum. Mol. Genet. 2000. V. 9, № 1. P. 57-61.</mixed-citation><mixed-citation xml:lang="en">Lambert J.-C., Brousseau T., Defoss et al. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations. the ECTIM Study // Hum. Mol. Genet. 2000. V. 9, № 1. P. 57-61.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lehtinen S., Lehtimaki T., Sisto T. et al. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women//Atherosclerosis. 1995. 114(1). Р. 83-91.</mixed-citation><mixed-citation xml:lang="en">Lehtinen S., Lehtimaki T., Sisto T. et al. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women//Atherosclerosis. 1995. 114(1). Р. 83-91.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Luigi Ferrucci, Jack M. Guralnik, Marco Pahor et al. Apolipoprotein E2 Allele and Risk of Stroke in the Older Population//Stroke. 1997. Dec. V. 28, № 12. P. 2410-2415.</mixed-citation><mixed-citation xml:lang="en">Luigi Ferrucci, Jack M. Guralnik, Marco Pahor et al. Apolipoprotein E2 Allele and Risk of Stroke in the Older Population//Stroke. 1997. Dec. V. 28, № 12. P. 2410-2415.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Menzel H.-J., Kladetzky R.-G., Assman G. Apolipoprotein E polimorphism and coronary artery disease//Arteriosclerosis. 1983. 3. Р. 310-315.</mixed-citation><mixed-citation xml:lang="en">Menzel H.-J., Kladetzky R.-G., Assman G. Apolipoprotein E polimorphism and coronary artery disease//Arteriosclerosis. 1983. 3. Р. 310-315.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">MONICA Manual, Section 2: Stroke event registration data component. 1990. Р. 3-12.</mixed-citation><mixed-citation xml:lang="en">MONICA Manual, Section 2: Stroke event registration data component. 1990. Р. 3-12.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Muros M., Rodreguez-Ferrer C. Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4//Atherosclerosis. 1996. 121(1). Р. 13-21.</mixed-citation><mixed-citation xml:lang="en">Muros M., Rodreguez-Ferrer C. Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4//Atherosclerosis. 1996. 121(1). Р. 13-21.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Paik Y.K., Chang D.J., Reardon C.A. et al. Nucleotide sequence and structure of the human apolipoprotein E gene//Proc. Natl. Acad. Sci. USA 1989. 82: 3445-3449.</mixed-citation><mixed-citation xml:lang="en">Paik Y.K., Chang D.J., Reardon C.A. et al. Nucleotide sequence and structure of the human apolipoprotein E gene//Proc. Natl. Acad. Sci. USA 1989. 82: 3445-3449.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts//Lancet. 1995. 346. Р. 1647-1653.</mixed-citation><mixed-citation xml:lang="en">Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts//Lancet. 1995. 346. Р. 1647-1653.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Thorvaldsen P., Kuulasmaa K.RAJAKANGAS АМ, RASTENYTE О, SARTI С, WILHELMSEN L, WORLD HEALTH ORGANIZATION MONICA PROJECT, GAFAROV V.V Stroke Trends in the WHO MONICA Project//Stroke. 1997. 28. Р. 500-506.</mixed-citation><mixed-citation xml:lang="en">Thorvaldsen P., Kuulasmaa K.RAJAKANGAS АМ, RASTENYTE О, SARTI С, WILHELMSEN L, WORLD HEALTH ORGANIZATION MONICA PROJECT, GAFAROV V.V Stroke Trends in the WHO MONICA Project//Stroke. 1997. 28. Р. 500-506.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tirschwell D.L., Smith N.L., Heckbert S.R. et al. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups//Neurology. 2004. 63. Р. 1868-1875.</mixed-citation><mixed-citation xml:lang="en">Tirschwell D.L., Smith N.L., Heckbert S.R. et al. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups//Neurology. 2004. 63. Р. 1868-1875.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Warlow C., Dennis S., Jan van Gijn et al. Stroke: a practical guide to management//2nd ed. Malden, MA: Blackwell Science. 2001. 151.</mixed-citation><mixed-citation xml:lang="en">Warlow C., Dennis S., Jan van Gijn et al. Stroke: a practical guide to management//2nd ed. Malden, MA: Blackwell Science. 2001. 151.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Willemse-van Son A. Association between apolipoprotein-E4 and long-term outcome after traumatic brain injury // The Journal of Neurology, Neurosurgery and Psychiatry. 2008. V. 1. P. 57-61.</mixed-citation><mixed-citation xml:lang="en">Willemse-van Son A. Association between apolipoprotein-E4 and long-term outcome after traumatic brain injury // The Journal of Neurology, Neurosurgery and Psychiatry. 2008. V. 1. P. 57-61.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Yamamura T, Tajima S, Miyake Y et al. Hyperlipoproteinemia as a risk factor for ischemic heart disease//Jpn. Circ. J. 1990. 54(4). Р. 448-456.</mixed-citation><mixed-citation xml:lang="en">Yamamura T, Tajima S, Miyake Y et al. Hyperlipoproteinemia as a risk factor for ischemic heart disease//Jpn. Circ. J. 1990. 54(4). Р. 448-456.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Juan Pedro-Botet, Mariano Senti, Xavier Nogues et al. Lipoprotein and Apolipoprotein Profile in Men With Ischemic Stroke Role of Lipoprotein (a), Triglyceride-Rich Lipoproteins, and Apolipoprotein E Polymorphism//Stroke. 1992. V. 23, № 11. Nov. Р. 1556-1562.</mixed-citation><mixed-citation xml:lang="en">Juan Pedro-Botet, Mariano Senti, Xavier Nogues et al. Lipoprotein and Apolipoprotein Profile in Men With Ischemic Stroke Role of Lipoprotein (a), Triglyceride-Rich Lipoproteins, and Apolipoprotein E Polymorphism//Stroke. 1992. V. 23, № 11. Nov. Р. 1556-1562.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
